Q4 2022 Holdings
Filed 2023-02-14 | 34 holdings | $162.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $19.6M | 1,849,402 | 12.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $11.6M | 396,500 | 7.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $11.2M | 217,500 | 6.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $11.2M | 1,100,000 | 6.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $9.2M | 33,000 | 5.6% |
| Sarepta Tehrapeutics Inc(SRPT) | COM | 803607100 | $8.7M | 67,500 | 5.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.3M | 324,614 | 5.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.7M | 360,500 | 4.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $7.6M | 290,500 | 4.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.9M | 144,500 | 4.3% |
| Cymabay Therapeutics Inc. Common Stock(CBAYUSD) | COM | 23257D103 | $6.4M | 1,015,000 | 3.9% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $6.2M | 501,500 | 3.8% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.6M | 950,000 | 3.4% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $5.2M | 632,500 | 3.2% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $5.1M | 115,000 | 3.2% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $5.1M | 260,000 | 3.1% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $4.1M | 500,000 | 2.5% |
| Aclaris Therapeutics(ACRS) | COM | 00461U105 | $4.0M | 255,000 | 2.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.8M | 80,000 | 2.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $2.4M | 243,250 | 1.5% |
| Argen SE(ARGX) | SPONSORED ADR | 04016X101 | $1.9M | 5,100 | 1.2% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $1.7M | 41,029 | 1.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.3M | 185,000 | 0.8% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $1.3M | 154,471 | 0.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.1M | 303,396 | 0.7% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $981.8K | 153,639 | 0.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $981.8K | 93,500 | 0.6% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $896.7K | 669,158 | 0.6% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $869.4K | 420,000 | 0.5% |
| Horizon Therapeutics PLC | SHS | G46188101 | $682.8K | 6,000 | 0.4% |
| Prothena Corporation PLC(PRTA) | SHS | G72800108 | $560.3K | 9,300 | 0.3% |
| Imara Inc | COM | 45249V107 | $182.0K | 44,503 | 0.1% |
| Kinnate Biopharma Inc | COM | 49705R105 | $30.5K | 5,000 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/2027 | 67080N119 | $13.1K | 90,832 | 0.0% |